miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS

Danilo Fiore, Elvira Donnarumma, Giuseppina Roscigno, Margherita Iaboni, Valentina Russo, Alessandra Affinito, Assunta Adamo, Fabio De Martino, Cristina Quintavalle, Giulia Romano, Adelaide Greco, Ylermi Soini, Arturo Brunetti, Carlo M. Croce, Gerolama Condorelli

Research output: Contribution to journalArticlepeer-review

Abstract

Glioblastoma is the most common primary brain tumor in adults; with a survival rate of 12 months from diagnosis. However, a small subgroup of patients, termed long-term survivors (LTS), has a survival rate longer then 12-14 months. There is thus increasing interest in the identification of molecular signatures predicting glioblastoma prognosis and in how to improve the therapeutic approach. Here, we report miR-340 as prognostic tumor-suppressor microRNA for glioblastoma. We analyzed microRNA expression in > 500 glioblastoma patients and found that although miR-340 is strongly down-regulated in glioblastoma overall, it is up-regulated in LTS patients compared to short-term survivors (STS). Indeed, miR-340 expression predicted better prognosis in glioblastoma patients. Coherently, overexpression of miR-340 in glioblastoma cells was found to produce a tumor-suppressive activity. We identified NRAS mRNA as a critical, direct target of miR-340: in fact, miR-340 negatively influenced multiple aspects of glioblastoma tumorigenesis by down-regulating NRAS and downstream AKT and ERK pathways. Thus, we demonstrate that expression of miR-340 in glioblastoma is responsible for a strong tumor-suppressive effect in LTS patients by down-regulating NRAS. miR-340 may thus represent a novel marker for glioblastoma diagnosis and prognosis, and may be developed into a tool to improve treatment of glioblastoma.

Original languageEnglish
Pages (from-to)19531-19547
Number of pages17
JournalOncotarget
Volume7
Issue number15
DOIs
Publication statusPublished - Apr 12 2016

Keywords

  • Glioblastoma
  • microRNAs
  • NRAS
  • Signal-transduction
  • Survival

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS'. Together they form a unique fingerprint.

Cite this